hVIVO plc

Healthcare GB HVO

28.8645GBP
0.11(0.40%)

Last update at 2024-09-05T07:38:00Z

Day Range

28.7728.87

LowHigh

52 Week Range

9.3623.50

LowHigh

Fundamentals

Previous Close 28.75
Market Cap153.66M
Volume342127
P/E Ratio-
Dividend Yield-%
EBITDA9.98M
Revenue TTM60.48M
Revenue Per Share TTM0.09
Gross Profit TTM 9.07M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Income before tax	-0.36500M	0.28M	-11.16300M	-5.65483M
Minority interest	-	-	-	-
Net income	-0.77600M	-0.07400M	-10.79100M	-5.58990M
Selling general administrative	23.54M	17.86M	10.96M	1.78M
Selling and marketing expenses	-	-	-	0.18M
Gross profit	48.48M	35.90M	19.88M	3.28M
Reconciled depreciation	-	-	-	-
Ebit	6.84M	0.24M	-8.66400M	-4.39640M
Ebitda	9.77M	2.80M	-6.61200M	-3.78555M
Depreciation and amortization	2.93M	2.56M	2.05M	0.61M
Non operating income net other	-	-	-	-
Operating income	6.02M	0.59M	-10.44200M	-4.98674M
Other operating expenses	42.34M	36.57M	29.16M	7.57M
Interest expense	0.13M	0.23M	0.37M	0.34M
Tax provision	-	-	-	-
Interest income	-	-	-	-
Net interest income	-	-	-	-
Extraordinary items	-	-	-	-
Non recurring	-	-	-	-
Other items	-	-	-	-
Income tax expense	0.41M	0.35M	-0.37200M	-0.06493M
Total revenue	48.48M	36.86M	20.60M	3.28M
Total operating expenses	42.34M	35.60M	28.43M	7.57M
Cost of revenue	-	0.96M	0.73M	-
Total other income expense net	-6.38800M	-0.31300M	-0.72100M	-0.66809M
Discontinued operations	-	-	-	-
Net income from continuing ops	-	-	-	-
Net income applicable to common shares	-	-	-	-
Preferred stock and other adjustments	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Total assets	51.38M	42.27M	48.55M	9.08M
Intangible assets	0.42M	0.62M	0.53M	0.21M
Earning assets	-	-	-	-
Other current assets	-	-	-	-
Total liab	31.16M	21.59M	26.25M	6.22M
Total stockholder equity	20.22M	20.68M	22.30M	2.86M
Deferred long term liab	-	-	-	-
Other current liab	26.24M	16.35M	16.47M	2.52M
Common stock	0.67M	0.67M	0.67M	0.25M
Capital stock	-	-	-	-
Retained earnings	24.46M	25.21M	-17.99300M	-7.00467M
Other liab	-	-	-	-
Good will	5.60M	5.60M	5.60M	2.68M
Other assets	-	-	-	-
Cash	28.44M	15.69M	19.20M	1.04M
Cash and equivalents	-	-	-	-
Total current liabilities	29.77M	20.69M	24.03M	5.19M
Current deferred revenue	-	16.35M	16.48M	-
Net debt	-26.88100M	-12.54600M	-14.40700M	2.10M
Short term debt	0.83M	2.29M	2.60M	2.16M
Short long term debt	-	-	-	-
Short long term debt total	1.56M	3.15M	4.80M	3.14M
Other stockholder equity	-4.91600M	-5.19700M	39.62M	9.61M
Property plant equipment	-	-	-	-
Total current assets	42.23M	25.34M	30.04M	4.68M
Long term investments	-	-	-	-
Net tangible assets	-	-	-	-
Short term investments	-	-	-	-
Net receivables	-	-	-	-
Long term debt	-	-	-	-
Inventory	0.50M	0.66M	0.95M	-
Accounts payable	2.70M	2.06M	4.95M	0.51M
Total permanent equity	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-
Accumulated other comprehensive income	-	-	-	-
Additional paid in capital	-	-	-	-
Common stock total equity	-	-	-	-
Preferred stock total equity	-	-	-	-
Retained earnings total equity	-	-	-	-
Treasury stock	-	-	-	-
Accumulated amortization	-	-	-	-
Non currrent assets other	-	7.00M	7.08M	-
Deferred long term asset charges	-	-	-	-
Non current assets total	9.15M	16.94M	18.50M	4.39M
Capital lease obligations	-	-	-	-
Long term debt total	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Investments	-	-	-	-
Change to liabilities	-	-	-	-
Total cashflows from investing activities	-	-	-	-
Net borrowings	-	-	-	-
Total cash from financing activities	-1.83400M	-1.19500M	13.04M	3.26M
Change to operating activities	-	-	-	-
Net income	-0.36500M	0.28M	-11.16300M	-5.65483M
Change in cash	12.75M	-3.51100M	18.17M	0.90M
Begin period cash flow	15.69M	19.20M	1.04M	0.14M
End period cash flow	28.44M	15.69M	19.20M	1.04M
Total cash from operating activities	15.98M	-1.56400M	4.17M	-2.77744M
Issuance of capital stock	-	-	-	-
Depreciation	2.93M	2.56M	2.05M	0.61M
Other cashflows from investing activities	-	-	-	-
Dividends paid	-	-	-	-
Change to inventory	0.17M	0.29M	-0.02800M	-
Change to account receivables	-	-	-	-
Sale purchase of stock	-	-	-	-
Other cashflows from financing activities	-1.54300M	-1.19000M	-3.63100M	-1.02520M
Change to netincome	-	-	-	-
Capital expenditures	1.36M	0.74M	1.09M	0.02M
Change receivables	-	-	-	-
Cash flows other operating	-	-	-	-
Exchange rate changes	-	-	-	-
Cash and cash equivalents changes	-	-	-	-
Change in working capital	7.01M	-1.77400M	11.58M	1.23M
Stock based compensation	0.28M	0.03M	0.24M	0.10M
Other non cash items	6.12M	-2.65900M	1.46M	0.94M
Free cash flow	14.62M	-2.30300M	3.08M	-2.80050M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company	Change (GBP)	Price (GBP)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
HVO hVIVO plc	0.11 0.40%	28.86	-	18.52	2.54	7.28	2.22	22.76
ONT Oxford Nanopore Technologies Ltd	0.10 0.07%	140.90	-	-	10.88	2.75	8.77	-16.7946
GNS Genus PLC	-16.9139 0.94%	1777.09	42.59	25.71	2.08	2.46	2.31	16.39
PRTC PureTech Health plc	2.82 1.81%	159.22	-	-	35.55	1.04	95.87	-4.5333
AVCT Avacta Group PLC	-0.55 0.76%	71.65	-	-	23.19	14.78	20.75	-10.4566

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.